Accent Microcell

Accent Microcell Net Debt per Share

The Net Debt per Share of Accent Microcell (ACCENTMIC.NS) as of Nov 14, 2026 is -20.63 INR. In the previous year, Net Debt per Share was -24.89 INR — a change of -17.09% (higher).

Net Debt per Share

-20.63INR

YoY

-17.09%

Last updated:

Net Debt per Share of Accent Microcell is 2025 -20.63 INR. Net Debt per Share of Accent Microcell was 2024 -24.89 INR. It decreases by -17.09% higher compared to the previous year.

The Accent Microcell Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2023
8.65 INR
Jan 1, 2024
-24.89 INR
Jan 1, 2025
-20.63 INR
The Accent Microcell Net Debt per Share history
YEARNet Debt per ShareYoY
-20.63INR-17.09%
-24.89INR-387.56%
8.65INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Accent Microcell Stock analysis

What does Accent Microcell do? Accent Microcell Ltd develops, processes, and markets a wide range of pharmaceutical products including bulk drugs, formulations in all forms, feed and dietary supplements, and healthcare products across allopathic, ayurvedic, umami, homeopathic, and other branches. The company manufactures and sells antibiotics, herbal, bacteriological, and biological products, as well as insecticides, pesticides, fungicides, and disinfectants. With over 200 products in its portfolio, Accent Microcell targets therapeutic segments in human and veterinary healthcare, offering both raw materials and finished preparations for diverse medical applications. The company's product range includes microcrystalline cellulose powder and alpha cellulose powder, which are used as pharmaceutical excipients. Accent Microcell Limited deals in all kinds of drugs and medicines, covering various therapeutic areas such as antibiotics, herbal remedies, and veterinary applications. Its business model focuses on manufacturing, importing, and exporting these products to meet demand in multiple healthcare sectors. Accent Microcell Ltd's revenue streams come from selling bulk drugs, pharmaceutical formulations, and healthcare products to distributors, pharmacies, and veterinary suppliers. The company's diverse portfolio of over 200 products ensures steady demand across different therapeutic segments, supporting consistent sales in both human and veterinary healthcare markets. Accent Microcell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Accent Microcell stock

Net Debt per Share of Accent Microcell is -20.63 INR in 2025.

Net Debt per Share of Accent Microcell changed from -24.89 INR to -20.63 INR, representing a -17.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Accent Microcell since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Accent Microcell

All Key Metrics — Accent Microcell